Nitrogenous metabolic wastes (Gut microbial metabolism)

Nitrogenous metabolic wastes, including urea, ammonia, and creatinine, are byproducts of protein metabolism that are typically cleared by the kidneys. In conditions like chronic kidney disease (CKD) or liver failure, these wastes accumulate and translocate into the gastrointestinal tract, where they interact with the gut microbiota (Ramezani & Raj, 2014). Gut microbial metabolism of these wastes involves enzymes like urease, which converts urea into ammonia, and other pathways that produce toxic metabolites like indoxyl sulfate and p-cresyl sulfate (Vaziri et al., 2013). This target represents a therapeutic focus where the gut is used as a surrogate kidney or bioreactor to remove nitrogenous burdens. Pharmacological interventions include oral adsorbents like AST-120, which bind toxin precursors, and probiotics or engineered bacteria like SYNB1020 that sequester or degrade nitrogenous compounds (Schulman et al., 2006; Kurtz et al., 2019). By modulating this microbial metabolism, clinicians aim to reduce systemic uremic toxicity and slow the progression of renal or hepatic complications.

Other names

Uremic toxinsNitrogenous solutesGut-derived uremic toxinsMicrobial nitrogen metabolismEnterohepatic nitrogen cycle

Therapeutic strategies involve the adsorption of nitrogenous precursors (e.g., indole) by oral sorbents, the sequestration of ammonia by engineered bacteria, or the enzymatic degradation of urea and other wastes by probiotic consortia to reduce systemic toxin levels (Vaziri et al., 2013; Kurtz et al., 2019).